[Therapy of parkinsonian syndromes and plasmatic DOPA levels. Effects of L-DOPA and 3-OMD, administered alone or combined, with or without a decarboxylase inhibitor].
作者信息
Geissbühler F, Gaillard J M, Eisenring J J, Krassoievitch M, Yanniotis G, Tissot R